Cargando…
Current guidelines for high-density lipoprotein cholesterol in therapy and future directions
Many studies have suggested that a significant risk factor for atherosclerotic cardiovascular disease (ASCVD) is low high-density lipoprotein cholesterol (HDL-C). Therefore, increasing HDL-C with therapeutic agents has been considered an attractive strategy. In the prestatin era, fibrates and niacin...
Autores principales: | Subedi, Bishnu H, Joshi, Parag H, Jones, Steven R, Martin, Seth S, Blaha, Michael J, Michos, Erin D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986285/ https://www.ncbi.nlm.nih.gov/pubmed/24748800 http://dx.doi.org/10.2147/VHRM.S45648 |
Ejemplares similares
-
Accuracy of low-density lipoprotein cholesterol estimation at very low levels
por: Quispe, Renato, et al.
Publicado: (2017) -
High-density lipoprotein and endothelial function in patients with
myocardial infarction: Pieces in a puzzle
por: Martin, Seth S., et al.
Publicado: (2014) -
Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels
por: Sajja, Aparna, et al.
Publicado: (2021) -
Narrowing Sex Differences in Lipoprotein Cholesterol Subclasses Following Mid‐Life: The Very Large Database of Lipids (VLDL‐10B)
por: Swiger, Kristopher J., et al.
Publicado: (2014) -
Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)